MKI67 and neoplasm: The combination of anti-PD-1 with IT CXCL9/10-DC induced an overall increase in cytotoxic GzmB+CD8+ and proliferative Ki67+CD8+ T cells across all of the regions of the TME compared to monotherapies, with the most pronounced increase observed at the tumor border (0–200) (Figure 6D).